Genelux (GNLX) Debt Ratio (2022)

Genelux's (GNLX) quarterly Debt Ratio came in at 0.2 in Q4 2022.

Genelux (GNLX) Debt Ratio (2022) Analysis & Trends

Genelux's Debt Ratio history runs 1 years deep, the most recent figure standing at 0.2 for Q4 2022.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.2 in Q4 2022; TTM through Dec 2022 was 0.2, a N/A change from a year earlier, with the FY2022 full-year figure at 0.2, changed N/A from the prior year.
Debt Ratio held at 0.2 in Q4 2022 per GNLX's latest filing.
Across five years, Debt Ratio topped out at 0.2 in Q4 2022 and bottomed at 0.2 in Q4 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	1.41
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	0.11
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	0.05
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	-
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	-
10	Genelux	129.36 Mn	129.36 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2022	0.20